new_0222_0497|MIRM|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0497|MIRM|1|Mirum Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Mirum Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Mirum Pharmaceuticals Inc Inventories (Quarterly) (USD)|Mirum Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Mirum Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Mirum Pharmaceuticals Inc Book Value (Quarterly) (USD)|Mirum Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Mirum Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Mirum Pharmaceuticals Inc EV to Revenues|Mirum Pharmaceuticals Inc EV to Earnings|Mirum Pharmaceuticals Inc EV to Free Cash Flow|Mirum Pharmaceuticals Inc EV to Assets (Quarterly)|Mirum Pharmaceuticals Inc PS Ratio|Mirum Pharmaceuticals Inc PE Ratio|Mirum Pharmaceuticals Inc Price to Book Value|Mirum Pharmaceuticals Inc PEG Ratio|Mirum Pharmaceuticals Inc Debt to Equity Ratio|Mirum Pharmaceuticals Inc Dividend Yield|Mirum Pharmaceuticals Inc Shareholder Yield (TTM)|Mirum Pharmaceuticals Inc Percent of Shares Outstanding Short|Mirum Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Mirum Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Mirum Pharmaceuticals Inc Return on Invested Capital|Mirum Pharmaceuticals Inc Quality Ratio Score|Mirum Pharmaceuticals Inc Momentum Score|Mirum Pharmaceuticals Inc Beta (1Y)|Mirum Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Mirum Pharmaceuticals Inc Institutional Investor Ownership Percentage|Mirum Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Mirum Pharmaceuticals Inc Total Employees (Annual)|Mirum Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Mirum Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Mirum Pharmaceuticals Inc Shares Outstanding|Mirum Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Mirum Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Mirum Pharmaceuticals Inc Payout Ratio|Mirum Pharmaceuticals Inc Quick Ratio (Quarterly)|Mirum Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Mirum Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Mirum Pharmaceuticals Inc Effective Tax Rate (TTM)|Mirum Pharmaceuticals Inc Return on Equity|Mirum Pharmaceuticals Inc Net Income (TTM) (USD)|Mirum Pharmaceuticals Inc Revenue (TTM) (USD)|Mirum Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Mirum Pharmaceuticals Inc Revenue (Quarterly) (USD)|Mirum Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Mirum Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Mirum Pharmaceuticals Inc Net Income (Quarterly) (USD)|Mirum Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Mirum Pharmaceuticals Inc Price (USD)|Mirum Pharmaceuticals Inc Total Return Price (USD)|Mirum Pharmaceuticals Inc Enterprise Value (USD)|Mirum Pharmaceuticals Inc 30-Day Average Daily Volume|Mirum Pharmaceuticals Inc 1 Year Price Returns (Daily)|Mirum Pharmaceuticals Inc Short Interest|Mirum Pharmaceuticals Inc PE Ratio (Forward)|Mirum Pharmaceuticals Inc PE Ratio (Forward 1y)|Mirum Pharmaceuticals Inc PS Ratio (Forward)|Mirum Pharmaceuticals Inc PS Ratio (Forward 1y)|Mirum Pharmaceuticals Inc Quarterly EPS Estimates (USD)|Mirum Pharmaceuticals Inc Quarterly Revenue Estimates (USD)|Mirum Pharmaceuticals Inc Quarterly EPS Surprise|Mirum Pharmaceuticals Inc Quarterly Revenue Surprise|Mirum Pharmaceuticals Inc Quarterly Actual EPS (USD)|Mirum Pharmaceuticals Inc Quarterly Actual Revenue (USD)|Mirum Pharmaceuticals Inc Revenue Estimates for Current Fiscal Year (USD)|Mirum Pharmaceuticals Inc Revenue Estimates for Next Fiscal Year (USD)|Mirum Pharmaceuticals Inc Price Target (USD)|Mirum Pharmaceuticals Inc Consensus Recommendation|Mirum Pharmaceuticals Inc Price Target Num Estimates|Mirum Pharmaceuticals Inc EPS Estimates for Current Fiscal Year (USD)|Mirum Pharmaceuticals Inc EPS Estimates for Next Fiscal Year (USD)|Mirum Pharmaceuticals Inc Research and Development Expense (Quarterly) (USD)|Mirum Pharmaceuticals Inc Reconciled Depreciation (Quarterly) (USD)|Mirum Pharmaceuticals Inc Non-Operating Interest Expense (Quarterly) (USD)|Mirum Pharmaceuticals Inc Land and Improvements (Quarterly) (USD)|Mirum Pharmaceuticals Inc Buildings and Improvements (Quarterly) (USD)|Mirum Pharmaceuticals Inc Other Properties (Quarterly) (USD)|Mirum Pharmaceuticals Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0497|MIRM|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0497|MIRM|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0497|MIRM|5|91.4|91.4||91.4||91.4|91.4|91.4||91.4|91.4||||1.44712430427|92|||1.44610281924||92|1.44648318043||15.25||91.4|91.4|||32.375|30.5|||99.6363636364|85.3|99.6363636364|99.6363636364|31.5555555556||91.4||92|99.6363636364|91.4|91.2857142857||91.375|||92||99.6363636364|99.6363636364|99.6363636364|6.95588235294|6.95588235294|6.95588235294|1.448|1.44139650873|15.25|||1.44712430427|1.44712430427|91.3333333333|91.3333333333|91.2857142857|90.5|91.2857142857|91.2857142857|21.3953488372|24.2105263158|22.4390243902|9.2|22.4390243902|21.3953488372|19.5744680851|99.6363636364|91.4|91.3333333333|||91.4|||
new_0222_0497|MIRM|6|10|10||10||10|10|10||10|10||||539|1|||603||1|654||60||10|10|||16|18|||11|10|11|11|27||10||1|11|10|7||8|||1||11|11|11|136|136|136|625|401|60|||539|539|12|12|7|2|7|7|43|38|41|100|41|43|47|11|10|6|||10|||
new_0222_0497|MIRM|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0497|MIRM|201809||||||||||||||||||||||||||||||||||10.0063||-0.0067|0.062||||||-0.0067|||||||||-0.067|-0.067|-0.002||||||||||||||||||||||||0.003||||||||
new_0222_0497|MIRM|201903|49.756|49.493||1.317||67.562|6.523|61.039||-16.062|-23.305|||||||||||||||2.375|6.991|||||||10.0063|24|-0.5953|1.321|||23.0158|||-0.5953|||||||||-5.957|-5.957|0.232||||||||||||||||||||||||4.863|0.027||||1.317|||
new_0222_0497|MIRM|201906|84.858|84.192||1.429||132.216|11.108|121.108||-27.95|-36.862|||||||||||||0.2554||2.348|6.991|||||||23.0158|25|-0.589|2.445|23.0158||23.0158|||-0.589|||||||||-13.557|-13.557|0.468|13.78|13.78|232.9657|60126.7667||58784|||||||||||||25|1.4|5|-3.31|-3.3206|11.589|0.088||||1.429||12.88|
new_0222_0497|MIRM|201909|129.317|126.259||1.572||12.07|10.909|1.161||146.203|-51.949||||||||1.5528|||||0.1682||2.665|0.002|||||||17.9961|29|-0.84|3.708|22.5669||22.5669|||-0.84|-67.2|||-34.668|||||-15.087|-15.087|0.785|9.61|9.61|136.7419|47863.8667||37951|||||||||||||25|1.4|5|-3.0828|-3.0487|12.159|0.089||||1.572||7.18|7.42
new_0222_0497|MIRM|201912|119.363|116.66||3.733||16.363|13.076|3.287||130.349|-69.901||||-11.036||||4.2514|||||1.1895||3.351|0.002|||||||22.6003|33|-0.79|4.278|22.6003||22.6003|||-0.79||-0.04||-52.553|||||-17.931|-17.952|0.747|25.18|25.18|442.5371|613631.8||268833|||66.4991|7.3057|-0.847||6.7285||-0.79||||30.4|1.4|5|-3.6092|-3.4141|14.38|0.12||||3.733||16.87|15.79
new_0222_0497|MIRM|202003|162.436|159.531||3.677||16.685|13.548|3.137||156.118|-91.211||||-3.4328||||2.2449|||||2.0977||3.265|0.003|||||||24.7047|41|-0.86|4.692|25.0337||25.0337|||-0.86|-44.659|-0.0368||-67.906|||||-21.306|-21.31|0.749|13.99|13.99|233.0942|84963.8333||525138|||42.0566|4.6204|-0.8363||-2.8327||-0.86|||15.0107|29.4|1.4|5|-3.5319|-4.3916|17.34|0.156||||3.677||16.9|16.74
new_0222_0497|MIRM|202006|152.075|149.336||3.53||19.558|16.58|2.978||136.208|-114.462||||-5.2365||||3.5819|||||2.5439||3.024|0.003|||9|2.0404|||25.0561|54|-0.93|5.042|25.0713||25.0713|||-0.93|-0.025|-0.0361||-77.6|||||-23.248|-23.251|0.405|20.8|20.8|368.581|128379.8333|63.4345|637799|||58.5465|6.432|-0.8732||-6.5072||-0.93|||12.416|35.1667|1.3333|6|-3.5773|-4.5628|18.555|0.147||||3.53||21.38|25.96
new_0222_0497|MIRM|202009|138.151|133.749||3.378||21.61|18.792|2.818||120.255|-135.968||||-5.2738||||4.0399|||||2.4846||5.177|0.003|||9|2.1811|||25.1329|67|-0.86|5.732|25.2109||25.2109|||-0.86|-2.271|-0.0298||-84.019|||||-21.509|-21.506|0.237|19.36|19.36|342.3906|77332.8|91.5507|626394|||58.2977|6.4047|-0.9824||12.4584||-0.86|||14.5832|48.7143|1.2857|7|-3.7489|-4.7838|15.984|0.155||||3.378||17.59|21.63
new_0222_0497|MIRM|202012|236.35|231.82||3.242||68.769|18.462|50.307||172.095|-173.171||||-3.226||||3.021|||||3.4167||3.151|0.003|||10|1.9911|||26.1123|68|-1.43|7.225|29.7765||29.7765|||-1.43|-84.916|-0.0058||-103.27|||||-37.201|-37.203|-0.167|19.54|19.54|442.0342|263864.3|-28.7928|1017370|||6.854|11.4113|-0.9829|8.3333|-45.4849|-100|-1.43||8.3333|14.4706|49.2857|1.2857|7|-3.5961|-4.3458|29.726|0.165|0.335|||3.242||19.25|18.78
new_0222_0497|MIRM|202103|217.755|213.113||3.06||88.358|35.022|53.336||133.883|-223.703||||-4.012||||4.4705|||||2.5961||5.658|0.003|||4|3.2088|||30.105|85|-1.68|9.479|30.1981||30.1981|||-1.6881|-6.994|-0.0053||-132.492|||||-50.527|-50.532|-3.232|18.99|18.99|345.8501|153740.7667|41.5714|783974|||7.8906|13.1371|-0.985|8.3333|-70.5584|-100|-1.68||24.2447|103.612|50.2857|1.2857|7|-4.086|-2.4833|38.134|0.185|3.381|||3.06||19.27|15.84
new_0222_0497|MIRM|202106|228.366|223.851||2.885||151.931|29.028|122.903||95.737|-267.597||||-2.5192|1.2126|||5.4753|||||2.2227||5.38|0.003|||2|3.9798|||30.2747|120|-1.45|13.353|30.3172||30.3172||7.7116|-1.4193|-0.938|-0.0098||-153.135|||11||-43.883|-43.894|-4.696|17.5|17.5|319.8215|98387.5333|-11.1511|673860|||6.9105|11.5053|-1.0775|1.8352|-34.5708|499.3995|-1.45|11|38.7821|89.3317|50.2857|1.2857|7|-6.53|-3.9833|35.048|0.175|4.776|||2.885||14.1|16.25
new_0222_0497|MIRM|202109|196.805|190.034||2.724|19|178.771|50.387|128.384||56.396|-314.705||||-3.0577|1.7675|||10.74|||||1.5759|0.4|5.003|0.003|||2|1.9695|||30.3677|137|-1.55|17.353|30.4063||30.4063||3.7794|-1.5826|-0.345|-0.0151||-178.737|||5||-47.099|-47.108|-5.595|18.75|18.75|348.3202|251466.5667|3.3731|479159|||7.9851|13.2944|-1.496||-6.6831||-1.596|5|38.2523|89.567|54.5714|1.4286|7|-5.412|-3.9765|30.471|0.178|5.667|||2.724||15.8|14.23
new_0222_0497|MIRM|202112|||||||||||||||-2.1969||||8.6651|||||1.4756||||||2|-1.4469||||||||||||||||||||||||15.93|15.93|298.0325|135719.9|-8.6483|452089|||10.726|3.5335|1.8378|62.667|||||78.422|145.6756|55.4286|1.4286|7|-5.0342|-4.8745||||||||17.72|23.12
new_0222_0497|MIRM|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.35|8.041||||||||||||||||||||
new_0222_0497|MIRM|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.27|12.0768||||||||||||||||||||
new_0222_0497|MIRM|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.24|15.9497||||||||||||||||||||
new_0222_0497|MIRM|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.06|22.4782||||||||||||||||||||